Washington, D.C. – The Campaign for Personal Prescription Importation (CPPI) predicts that drug price hikes in 2021 will drive increased prescription importation. Some 929 drugs saw price increases in January 2021. Reports from healthcare research firm 3 Axis Advisors and announcements by drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc, show plans for drug price hikes by as much as 10.4% in 2021.
“It is unconscionable that BigPharma would hike drug prices amid the pandemic, and it is a move certain to continue driving Americans toward importing their medications in larger numbers,” said Jack Pfeiffer, executive director of the Campaign for Personal Prescription Importation. “These early reports of price hikes are just the beginning of cost increases that Americans can expect in 2021. Americans, wise to the BigPharma racket, are finding the savings they need and deserve at online pharmacies like those in Canada.”